已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Efficacy and Safety of Doxepin 1 mg, 3 mg, and 6 mg in Elderly Patients With Primary Insomnia: A Randomized, Double-Blind, Placebo-Controlled Crossover Study

多塞平 原发性失眠 安慰剂 医学 失眠症 睡眠起始潜伏期 睡眠开始 麻醉 多导睡眠图 睡眠障碍 交叉研究 人口 内科学 精神科 病理 替代医学 环境卫生 呼吸暂停
作者
Martin B. Scharf,Roberta Rogowski,Steven G. Hull,Martin A. Cohn,David W. Mayleben,Neil T. Feldman,Larry Ereshefsky,Alan Lankford,Thomas G. Roth
出处
期刊:The Journal of Clinical Psychiatry [Physicians Postgraduate Press, Inc.]
卷期号:69 (10): 1557-1564 被引量:112
标识
DOI:10.4088/jcp.v69n1005
摘要

OBJECTIVES: Evaluate efficacy and safety of the histamine-H1 antagonist doxepin at doses of 1 mg, 3 mg, and 6 mg in elderly adults with primary insomnia. DESIGN: A randomized, double-blind, placebo-controlled, crossover design was used in this population of elderly adults with primary insomnia (DSM-IV). Each treatment period consisted of 2 polysomnographic (PSG) assessment nights with a 5- or 12-day drug-free interval between periods. The study was conducted from September 2004 to January 2005. SETTING: Sleep laboratories in 11 sleep centers in the United States. PARTICIPANTS: Elderly adults with primary insomnia. INTERVENTION: Doxepin 1 mg, 3 mg, and 6 mg. MEASUREMENTS: Efficacy was assessed using PSG and patient-reported measures. RESULTS: Seventy-six patients were randomly assigned. All 3 doxepin doses produced dose-related significant improvements in PSG-determined wake time during sleep (p < .0001), wake time after sleep onset (p < .0001), total sleep time (p < .0001), and overall sleep efficiency (p < .0001) versus placebo. At the 3-mg and 6-mg doses, sleep efficiency was significantly improved during all thirds of the night (p < .05). There was a dose-related decrease in patient-reported sleep latency, with the 6-mg dose achieving statistical significance in latency to sleep onset (p = .0181). The pattern of the remaining subjective efficacy results was consistent with PSG. All 3 doxepin doses had side effect profiles comparable to placebo, with no spontaneously reported anticholinergic effects, no memory impairment, and no significant next-day residual effects. CONCLUSIONS: In this 2-night study of elderly adults with primary insomnia, doxepin doses of 1 mg, 3 mg, and 6 mg were well tolerated and produced significant improvement in objective and subjective sleep maintenance and duration endpoints that persisted into the final hour of the night. Positive effects on patient-reported sleep onset were observed at the highest dose. All 3 doxepin doses had a safety profile comparable to placebo. These data demonstrate that doxepin was efficacious in improving sleep in elderly adults.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
CHean发布了新的文献求助20
刚刚
hanshishengye完成签到 ,获得积分0
2秒前
2秒前
5秒前
成就舞仙完成签到,获得积分10
7秒前
7秒前
大力的无声完成签到,获得积分10
8秒前
平常映雁发布了新的文献求助10
8秒前
lb完成签到,获得积分10
10秒前
11秒前
小二郎的应助被Clearday采纳,获得10
11秒前
二呆熊发布了新的文献求助10
12秒前
小丑完成签到,获得积分10
12秒前
LUYAO1完成签到 ,获得积分10
12秒前
xl_c完成签到 ,获得积分10
12秒前
12秒前
K2C完成签到,获得积分10
17秒前
ZM完成签到,获得积分10
17秒前
Ava的应助被二呆熊采纳,获得10
19秒前
小巧的白容完成签到,获得积分10
19秒前
20秒前
无花果的应助被Flynn采纳,获得10
20秒前
科研通AI2S的应助被科研通管家采纳,获得50
20秒前
lukou关注了科研通微信公众号
21秒前
Nole的应助被科研通管家采纳,获得10
21秒前
ding的应助被科研通管家采纳,获得10
21秒前
英俊的铭的应助被科研通管家采纳,获得10
21秒前
mountainbike完成签到,获得积分10
21秒前
21秒前
Nole的应助被科研通管家采纳,获得10
21秒前
打打的应助被科研通管家采纳,获得10
21秒前
CAOHOU的应助被科研通管家采纳,获得10
21秒前
传奇3的应助被科研通管家采纳,获得10
22秒前
疯狂的凡梦完成签到 ,获得积分10
22秒前
dmmmm0903发布了新的文献求助30
23秒前
ttang11完成签到,获得积分10
23秒前
呆呆完成签到 ,获得积分10
24秒前
跳跃雨柏完成签到,获得积分10
24秒前
鹿鹿七完成签到 ,获得积分10
25秒前
25秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179547
求助须知:如何正确求助?哪些是违规求助? 9569910
关于积分的说明 21807373
捐赠科研通 7775016
什么是DOI,文献DOI怎么找? 3433072
关于科研通互助平台的介绍 2556999
邀请新用户注册赠送积分活动 2478760